Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Molecular Cell|June 16, 2009
Potent transcriptional interference by pausing of RNA polymerases over a downstream promoterAdam C Palmer, Alexandra Ahlgren-Berg, J Barry Egan, et al.Blood Cancer Discovery|October 27, 2025
A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell LymphomaAmy E Pomeroy, Brian J Sworder, Deborah Plana, et al.Journal of the National Cancer Institute|July 11, 2026
When survival improves but quality of life does not: a model-based meta-analysis of immune checkpoint inhibitorsYimeng Sun, Shiwon Chang, Kayden Tang, et al.Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
When Survival Improves But Quality of Life Does Not: A Model-Based Meta-Analysis of Immune Checkpoint InhibitorsYimeng Sun, Shiwon Chang, Kayden Tang, et al.Computational and Structural Biotechnology Journal|September 23, 2022
Mechanisms of antibiotic action shape the fitness landscapes of resistance mutationsColin Hemez, Fabrizio Clarelli, Adam C Palmer, et al.Journal of Molecular Biology|January 27, 2005
A mathematical model for transcriptional interference by RNA polymerase traffic in Escherichia coliKim Sneppen, Ian B Dodd, Keith E Shearwin, et al.Nature Communications|August 29, 2018
Modeling the impact of drug interactions on therapeutic selectivityZohar B Weinstein, Nurdan Kuru, Szilvia Kiriakov, et al.Journal of Hematology & Oncology|July 18, 2020
DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomasYonghan He, Raphael Koch, Vivekananda Budamagunta, et al.Cell Systems|May 13, 2019
Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic ReprogrammingHuan Wang, Robert P Sheehan, Adam C Palmer, et al.Med (New York, N.Y.)|April 29, 2026
Rethinking the role of synergy calculations in the next century of drug combination discoveryChristian T Meyer, Yunxing Dai, Amy E Pomeroy, et al.Pageof 5